Item 5.07. Submission of Matters to a Vote of Security Holders.
(a) The Annual Meeting of Shareholders of Merck & Co., Inc. (the "Company") was
held on May 24, 2022.
(b) Shareholders voted on the matters set forth below:

1.The following nominees were elected to the Company's Board of Directors to
hold office until the Company's next Annual Meeting of Shareholders and received
the number of votes set forth opposite their names:

                     Names                            Votes For             Votes Against          Abstentions              Broker
                                                                                                                           Non-Votes
Douglas M. Baker, Jr.                               1,780,984,040             6,528,771             4,691,991             323,364,405
Mary Ellen Coe                                      1,779,429,445             7,859,159             4,916,198             323,364,405
Pamela J. Craig                                     1,692,355,200            95,577,191             4,272,411             323,364,405
Robert M. Davis                                     1,774,674,995            12,884,351             4,645,456             323,364,405
Kenneth C. Frazier                                  1,732,254,447            54,859,038             5,091,317             323,364,405
Thomas H. Glocer                                    1,697,902,650            88,973,584             5,328,568             323,364,405
Risa J. Lavizzo-Mourey, M.D.                        1,756,457,228            31,502,898             4,244,676             323,364,405
Stephen L. Mayo, Ph.D.                              1,781,071,829             6,746,997             4,385,976             323,364,405
Paul B. Rothman, M.D.                               1,779,382,586             7,669,301             5,152,915             323,364,405
Patricia F. Russo                                   1,536,818,865            250,967,059            4,418,878             323,364,405
Christine E. Seidman, M.D.                          1,780,105,880             7,252,569             4,846,353             323,364,405
Inge G. Thulin                                      1,769,168,113            17,923,028             5,113,661             323,364,405
Kathy J. Warden                                     1,777,663,402            10,258,048             4,283,352             323,364,405
Peter C. Wendell                                    1,708,427,277            78,700,280             5,077,245             323,364,405

2.Non-binding advisory vote to approve the compensation of our named executive officers:



1,638,611,142 votes FOR

144,654,654 votes AGAINST

8,939,006 shares abstained from voting

323,364,405 broker non votes

3.Ratification of the appointment of the Company's independent registered public accounting firm for 2022:



2,026,097,702 votes FOR

83,727,641 votes AGAINST

5,743,867 shares abstained from voting

4.Shareholder proposal regarding independent board chairman:

615,122,318 votes FOR

1,168,095,979 votes AGAINST

8,986,505 shares abstained from voting

323,364,405 broker non votes

--------------------------------------------------------------------------------

5.Shareholder proposal regarding access to COVID-19 products:

627,659,497 votes FOR

1,117,396,234 votes AGAINST

47,149,071 shares abstained from voting

323,364,405 broker non votes

6.Shareholder proposal regarding lobbying expenditure disclosure:

286,221,316 votes FOR

1,492,430,156 votes AGAINST

13,553,330 shares abstained from voting

323,364,405 broker non votes

A majority of the votes cast was required for all six proposals to be approved.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses